CareDx
CareDx, Castle Bio, Lucira Health, Others Announce Preliminary Q4, FY21 Earnings Results
CareDx's Q4 revenues rose between 34 percent and 35 percent, while OpGen Q4 revenues were flat compared to the previous year.
CareDx to Study AlloSure Kidney for Routine Organ Transplant Surveillance in Pediatric Patients
The company is teaming up with the North American Pediatric Renal Trials and Collaborative Studies organization to study the long-term impact of AlloSure.
In Brief This Week: PerkinElmer, Labcorp, Illumina, Thermo Fisher Scientific, and More
News items for the in vitro diagnostics industry for the week of Nov. 15, 2021.
In Brief This Week: MDxHealth, Co-Diagnostics, HTG Molecular Diagnostics, Immunovia, and More
News items for the in vitro diagnostics industry for the week of Nov. 8, 2021.
Broader Markets Lift 360Dx Index 3 Percent in October
Of the 29 companies in the index, 14 saw increases in their stock prices, while 15 saw declines.
Oct 29, 2021
Jul 29, 2021
CareDx Q2 Revenues up 77 Percent
May 5, 2021
CareDx Q1 Revenues up 76 Percent
Feb 25, 2021
Feb 24, 2021
CareDx Q4 Revenues Up 64 Percent
Jan 21, 2021